Clinical trial · Observational
Active Symptom Monitoring in Patients Undergoing Radiation Therapy for Thoracic Malignancies
NCT04324645CI-TRIAL-00057534completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study seeks to achieve two aims: * To assess the implementation of Noona software for continuous symptom monitoring for a diverse population of patients with thoracic malignancies who are undergoing radiation and * To validate remote collection of standardized PRO measures using Noona software.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Radiation Therapy | — | UNRESOLVED | — |
| Symptom Monitoring | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Noona Software | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Active Symptom Monitoring via Noona
- description
- Participants will undergo a single training session on how to use the Noona software no more than 4-12 weeks before starting therapy. They can start using the software immediately after the training session. Patients will be invited to complete either the Chest Radiotherapy (if radiotherapy alone), Chemotherapy-18 (if chemoradiation therapy), or Bone Radiotherapy (if other) module at baseline, every other week throughout therapy, and during follow up for 90-days. Patients will be encouraged by the treatment team to complete the baseline symptom report prior to starting any therapy and to complete the reports during therapy and in follow up. Patients will also complete the EORTC QLQ-C30 and the NCCN Distress Thermometer at baseline (no more than 12 weeks before starting therapy), within 1 week of completing therapy, and at 90-days follow up. Patients will be encouraged to use Noona's other features beyond invited modules and PRO inventories, such as the diary during the study
- interventionNames
- Other: Noona Software
Primary outcomes (2)
- measure
- Percentage of invited symptom reports completed during the study period
- timeFrame
- Treatment through 90 days of follow-up (estimated to be 5 months)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Biopsy confirmed cancer. Radiographically apparent (i.e. not histologically or cytologically confirmed) malignancy of the thorax is allowed. * Currently planning to receive radiotherapy with or without chemotherapy for greater than one fraction. * Ability to understand and willingness to sign an IRB approved written informed consent document (or that of legally authorized representative, if applicable). * Age 18 years or older Exclusion Criteria: -Unable to reliably access and use a device compatible with Noona software.
References
Publications (0)
Data not yet available
No reference posted for this study.